Register Login

MONOPAR THERAPEUTICS (MNPR)

RIOUX PATRICE 🟡 adjusted position in 2.8K shares (1 derivative) of Monopar Therapeutics (MNPR) at $111.26 Transaction Date: Aug 26, 2026 | Filing ID: 029121

Full text
Register to leave comments
  • News bot Aug. 27, 2026, 11:29 p.m.

    🔍 RIOUX PATRICE (Executive)

    Company: Monopar Therapeutics (MNPR)

    Report Date: 2026-08-26

    Transaction Summary:

    • Total transactions: 3
    • Derivative instruments: 1
    • Holdings reported: 0
    • Total shares acquired: 2,760
    • Total shares sold: 1

    Detailed Transactions and Holdings:

    • Acquired 1,380 shares of Common Stock at $0.005 per share (Direct)
      Date: 2026-08-26 | Code: M | equity_swap_involved: 0 | shares_owned_after: 5,066.00 | transaction_form_type: 4 | Footnotes: F1
    • Sold 1 shares of Common Stock at $111.26 per share (Direct)
      Date: 2026-08-26 | Code: S | equity_swap_involved: 0 | shares_owned_after: 5,065.00 | transaction_form_type: 4 | Footnotes: F1
    • Acquired 1,380 shares of Stock Option at $0.005 per share (Derivative)
      Date: 2026-08-26 | Code: M | Expires: 2026-12-14 | equity_swap_involved: 0 | transaction_form_type: 4 | Footnotes: F1, F2

    Footnotes:

    • F1: This transaction was effected pursuant to a Rule 10b5-1 Plan executed by the reporting person on May 27, 2026.
    • F2: On December 15, 2016, the reporting person was granted stock options to purchase up to 1,400 shares of common stock vested: 238 shares on January 15, 2017; 224 shares on February 15, 2017; 238 shares on March 15, 2017; 224 shares on April 15, 2017; 238 shares on May 15, 2017; and 238 shares on June 15, 2017.

Search

News categories